We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

41 hedge funds and large institutions have $74.3M invested in VanEck Pharmaceutical ETF in 2013 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

31.2% more ownership

Funds ownership: 0% → 31.2% (+31%)

Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sandler Capital Management
New York
$18.5M +$18.8M +407,660 New
AACR
2
ACR Alpine Capital Research
Missouri
$12.6M +$12.8M +277,421 New
MIM
3
Macroview Investment Management
Maryland
$5.49M +$5.58M +120,628 New
Morgan Stanley
4
Morgan Stanley
New York
$4.98M +$5.06M +109,432 New
JP Morgan Chase
5
JP Morgan Chase
New York
$3.68M +$3.74M +80,977 New
CS
6
Credit Suisse
Switzerland
$3.64M +$3.7M +80,074 New
GIM
7
Guild Investment Management
California
$3.19M +$3.24M +70,150 New
Goldman Sachs
8
Goldman Sachs
New York
$3.02M +$3.07M +66,451 New
VF
9
Virtu Financial
New York
$2.45M +$2.49M +53,929 New
CC
10
Columbia Capital
California
$2.33M +$2.37M +51,331 New
MA
11
Montag & Associates
Georgia
$2.25M +$2.29M +49,540 New
Bank of America
12
Bank of America
North Carolina
$2.15M +$2.18M +47,203 New
PI
13
Placemark Investments
Illinois
$2.08M +$2.12M +45,748 New
MWR
14
McAdams Wright Ragen
Washington
$971K +$987K +21,345 New
PVH
15
Psagot Value Holdings
Israel
$709K +$721K +15,600 New
OC
16
Oppenheimer & Co
New York
$614K +$624K +13,497 New
HR
17
Howe & Rusling
New York
$580K +$590K +12,760 New
U
18
UBS
Switzerland
$506K +$514K +11,122 New
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$495K +$504K +10,907 New
KIA
20
KCM Investment Advisors
California
$442K +$450K +9,725 New
Bank of Montreal
21
Bank of Montreal
Ontario, Canada
$387K +$393K +8,505 New
LCM
22
LVM Capital Management
Michigan
$307K +$312K +6,745 New
RG
23
Redmile Group
California
$296K +$301K +6,500 New
FPCM
24
Financial Partners Capital Management
New York
$282K +$287K +6,212 New
MA
25
MUFG Americas
New York
$254K +$258K +5,570 New
1
2

PPH Hedge Fund Activity: Q2 2013 in Review

41 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q2 2013, worth a combined $74.3M.

Buyers outnumbered sellers: 41 funds opened new PPH positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $74.3M of VanEck Pharmaceutical ETF stock for Q2 2013.
  • 41 funds opened new VanEck Pharmaceutical ETF positions in Q2 2013 and 0 closed out, a net change of +41 holders.

Based on aggregated 13F filings for Q2 2013.